| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BDX | Common Stock | Options Exercise | $2.52M | +15K | +51.94% | $167.91 | 43.9K | Aug 15, 2022 | Direct | |
| transaction | BDX | Common Stock | Disposed to Issuer | -$1.46M | -5.5K | -12.53% | $265.13 | 38.4K | Aug 15, 2022 | Direct | |
| transaction | BDX | Common Stock | Sale | -$2.52M | -9.5K | -24.75% | $265.13 | 28.9K | Aug 15, 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BDX | Stock Appreciation Rights | Options Exercise | $0 | -15K | -49.7% | $0.00 | 15.2K | Aug 15, 2022 | Common Stock | 15K | $167.91 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $263.79 through $265.64. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 12, 2022. |
| F2 | Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
| F3 | Award terms reflect adjustments made in connection with the spin-off of Embecta Corp. |
| F4 | The stock appreciation rights vest in four annual installments beginning November 26, 2017. |